A-232
A chemical compound belonging to the Novichok class of nerve agents
A-232 is a nerve agent that belongs to the Novichok class of chemical weapons. These agents were developed in the Soviet Union during the late 20th century as part of a program to create more potent and undetectable chemical weapons. A-232 is known for its high toxicity and rapid action, making it a significant concern in the context of chemical warfare and chemical terrorism.
Chemical Structure
A-232 is an organophosphorus compound, characterized by the presence of a phosphorus atom bonded to various organic groups. The structure of A-232, like other Novichok agents, is designed to inhibit the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine in the synaptic cleft and resulting in continuous stimulation of muscles, glands, and central nervous system functions.
Mechanism of Action
A-232 acts by irreversibly binding to the active site of acetylcholinesterase, preventing the breakdown of acetylcholine. This leads to an overstimulation of cholinergic receptors throughout the body. The symptoms of exposure include muscle twitching, respiratory failure, convulsions, and potentially death if not treated promptly.
Symptoms of Exposure
Exposure to A-232 can occur through inhalation, skin contact, or ingestion. Symptoms typically manifest rapidly and include:
- Miosis (constricted pupils)
- Bronchoconstriction
- Excessive salivation
- Lacrimation (tearing)
- Muscle weakness
- Seizures
- Coma
Treatment
The primary treatment for A-232 exposure involves the administration of atropine and pralidoxime. Atropine acts as an antagonist to acetylcholine at muscarinic receptors, while pralidoxime reactivates acetylcholinesterase by removing the phosphate group attached by the nerve agent. Supportive care, including ventilation and seizure control, is also critical.
History and Development
The development of A-232 and other Novichok agents was part of a secretive Soviet program aimed at creating advanced chemical weapons that could evade detection by international monitoring systems. The existence of these agents was not widely known until the 1990s, following the dissolution of the Soviet Union.
International Concerns
The use of A-232 and other Novichok agents is prohibited under the Chemical Weapons Convention, an international treaty that aims to eliminate chemical weapons and prevent their use. Despite this, there have been reports of their use in assassination attempts and other illicit activities, raising significant international security concerns.
Related pages
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian